|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 11 (June 1), 1999:
pp. 3811-3823
Vascular Endothelial Cell Growth Factor-Induced Tissue Factor
Expression in Endothelial Cells Is Mediated by EGR-1
Diana Mechtcheriakova,
Alexander Wlachos,
Harry Holzmüller,
Bernd R. Binder, and
Erhard Hofer
From the Department of Vascular Biology and Thrombosis Research at
VIRCC, University of Vienna, Vienna, Austria.
Vascular endothelial cell growth factor (VEGF) is a major regulator
of angiogenesis. We report here that treatment of endothelial cells
with VEGF leads to upregulation of tissue factor mRNA and protein
expression on the cell surface. Reporter gene studies show that
transcriptional activation of the tissue factor gene by VEGF is
mediated by a GC-rich promoter element containing overlapping binding
sites for Sp1 and EGR-1. As shown by immunofluorescence and
electrophoretic mobility shift assays, upon VEGF treatment EGR-1
rapidly accumulates in the nucleus and binds to its respective recognition site in the tissue factor promoter. Sp1 occupies this element in unstimulated cells and seems to be partially displaced by
increasing amounts of EGR-1. Transfection of endothelial cells with an
EGR-1 expression plasmid mimics the upregulation of tissue factor
transcription observed after VEGF treatment. In contrast, NF B, the
major transcription factor involved in tissue factor upregulation by
inflammatory stimuli, is not activated by VEGF. These data show that
VEGF induces a response in endothelial cells largely distinct from
inflammatory stimuli, and suggest that EGR-1 is a major mediator of the
activation of the tissue factor and possibly other VEGF-responsive genes.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Md. R. Abid, K. C. Spokes, S.-C. Shih, and W. C. Aird
NADPH Oxidase Activity Selectively Modulates Vascular Endothelial Growth Factor Signaling Pathways
J. Biol. Chem.,
November 30, 2007;
282(48):
35373 - 35385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A Staton, A. S A Chetwood, I. C Cameron, S. S Cross, N. J Brown, and M. W R Reed
The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer
Gut,
October 1, 2007;
56(10):
1426 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G. S. Robinson, Y.-S. Ng, and D. T. Shima
Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain
J. Biol. Chem.,
September 21, 2007;
282(38):
28045 - 28056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Stannard, R. Khurana, I. M. Evans, V. Sofra, D. I.R. Holmes, and I. Zachary
Vascular Endothelial Growth Factor Synergistically Enhances Induction of E-Selectin by Tumor Necrosis Factor-{alpha}
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2007;
27(3):
494 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Md. R. Abid, S.-C. Shih, H. H. Otu, K. C. Spokes, Y. Okada, D. T. Curiel, T. Minami, and W. C. Aird
A Novel Class of Vascular Endothelial Growth Factor-responsive Genes That Require Forkhead Activity for Expression
J. Biol. Chem.,
November 17, 2006;
281(46):
35544 - 35553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Schoffski, H. Dumez, P. Clement, A. Hoeben, H. Prenen, P. Wolter, S. Joniau, T. Roskams, and H. Van Poppel
Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review
Ann. Onc.,
August 1, 2006;
17(8):
1185 - 1196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Rong, F. Hu, R. Huang, N. Mackman, J. M. Horowitz, R. L. Jensen, D. L. Durden, E. G. Van Meir, and D. J. Brat
Early Growth Response Gene-1 Regulates Hypoxia-Induced Expression of Tissue Factor in Glioblastoma Multiforme through Hypoxia-Inducible Factor-1-Independent Mechanisms.
Cancer Res.,
July 15, 2006;
66(14):
7067 - 7074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, J. F. Maddox, P. E. Ganey, and R. A. Roth
Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine
Toxicol. Sci.,
April 1, 2006;
90(2):
569 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Khachigian
Early Growth Response-1 in Cardiovascular Pathobiology
Circ. Res.,
February 3, 2006;
98(2):
186 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Malakooti, R. Sandoval, V. C. Memark, P. K. Dudeja, and K. Ramaswamy
Zinc finger transcription factor Egr-1 is involved in stimulation of NHE2 gene expression by phorbol 12-myristate 13-acetate
Am J Physiol Gastrointest Liver Physiol,
October 1, 2005;
289(4):
G653 - G663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ma, G. Francia, A. Viloria-Petit, D. J. Hicklin, J. du Manoir, J. Rak, and R. S. Kerbel
In vitro Procoagulant Activity Induced in Endothelial Cells by Chemotherapy and Antiangiogenic Drug Combinations: Modulation by Lower-Dose Chemotherapy
Cancer Res.,
June 15, 2005;
65(12):
5365 - 5373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kato, M. Pinto, A. Carvajal, N. Espinoza, C. Monso, A. Sadarangani, M. Villalon, J. J. Brosens, J. O. White, J. K. Richer, et al.
Progesterone Increases Tissue Factor Gene Expression, Procoagulant Activity, and Invasion in the Breast Cancer Cell Line ZR-75-1
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
1181 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shi, B. Reitmaier, J. Regenbogen, R. M. Slowey, S. R. Opalenik, E. Wolf, A. Goppelt, and J. M. Davidson
CARP, a Cardiac Ankyrin Repeat Protein, Is Up-Regulated during Wound Healing and Induces Angiogenesis in Experimental Granulation Tissue
Am. J. Pathol.,
January 1, 2005;
166(1):
303 - 312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Yauch, E. E. Kadel III, C. Nicholas, S. Tetangco, and D. O. Clary
Transcriptional-Based Screens for Pathway-Specific, High-Throughput Target Discovery in Endothelial Cells
J Biomol Screen,
December 1, 2004;
9(8):
704 - 711.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Weisz, A. Zalcenstein, P. Stambolsky, Y. Cohen, N. Goldfinger, M. Oren, and V. Rotter
Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function
Cancer Res.,
November 15, 2004;
64(22):
8318 - 8327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Md. R. Abid, I. G. Schoots, K. C. Spokes, S.-Q. Wu, C. Mawhinney, and W. C. Aird
Vascular Endothelial Growth Factor-mediated Induction of Manganese Superoxide Dismutase Occurs through Redox-dependent Regulation of Forkhead and I{kappa}B/NF-{kappa}B
J. Biol. Chem.,
October 15, 2004;
279(42):
44030 - 44038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Solovey, R. Kollander, A. Shet, L. C. Milbauer, S. Choong, A. Panoskaltsis-Mortari, B. R. Blazar, R. J. Kelm Jr, and R. P. Hebbel
Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin
Blood,
August 1, 2004;
104(3):
840 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Minami, A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird
Thrombin and Phenotypic Modulation of the Endothelium
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2004;
24(1):
41 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N A Chung, C Lydakis, F Belgore, F L Li-Saw-Hee, A D Blann, and G Y H Lip
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease
Heart,
December 1, 2003;
89(12):
1411 - 1415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Liu, H. Jia, D. I. R. Holmes, A. Stannard, and I. Zachary
Vascular Endothelial Growth Factor-Regulated Gene Expression in Endothelial Cells: KDR-Mediated Induction of Egr3 and the Related Nuclear Receptors Nur77, Nurr1, and Nor1
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2003;
23(11):
2002 - 2007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takeya, E. C. Gabazza, S. Aoki, H. Ueno, and K. Suzuki
Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells
Blood,
September 1, 2003;
102(5):
1693 - 1700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Watson, A. K. C. Chan, L. R. Berry, J. Li, S. K. Sood, J. G. Dickhout, L. Xu, G. H. Werstuck, L. Bajzar, H. J. Klamut, et al.
Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity
J. Biol. Chem.,
May 2, 2003;
278(19):
17438 - 17447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lucerna, D. Mechtcheriakova, A. Kadl, G. Schabbauer, R. Schafer, F. Gruber, Y. Koshelnick, H.-D. Muller, K. Issbrucker, M. Clauss, et al.
NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells
J. Biol. Chem.,
March 21, 2003;
278(13):
11433 - 11440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Q. Wu, T. Minami, D. J. Donovan, and W. C. Aird
The proximal serum response element in the Egr-1 promoter mediates response to thrombin in primary human endothelial cells
Blood,
December 15, 2002;
100(13):
4454 - 4461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.C. Kuenen, M. Levi, J.C.M. Meijers, A.K. Kakkar, V.W.M. van Hinsbergh, P.J. Kostense, H.M. Pinedo, and K. Hoekman
Analysis of Coagulation Cascade and Endothelial Cell Activation During Inhibition of Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Pathway in Cancer Patients
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2002;
22(9):
1500 - 1505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Bavendiek, P. Libby, M. Kilbride, R. Reynolds, N. Mackman, and U. Schonbeck
Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor kappa B, and Egr-1
J. Biol. Chem.,
July 5, 2002;
277(28):
25032 - 25039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Loewe, W. Holnthoner, M. Groger, M. Pillinger, F. Gruber, D. Mechtcheriakova, E. Hofer, K. Wolff, and P. Petzelbauer
Dimethylfumarate Inhibits TNF-Induced Nuclear Entry of NF-{kappa}B/p65 in Human Endothelial Cells
J. Immunol.,
May 1, 2002;
168(9):
4781 - 4787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. N. Bochkov, D. Mechtcheriakova, M. Lucerna, J. Huber, R. Malli, W. F. Graier, E. Hofer, B. R. Binder, and N. Leitinger
Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT
Blood,
January 1, 2002;
99(1):
199 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guha, M. A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S.-F. Yan, D. Stern, and N. Mackman
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor {alpha} expression by inducing Elk-1 phosphorylation and Egr-1 expression
Blood,
September 1, 2001;
98(5):
1429 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Kini, L. C. Peterson, M. S. Tallman, and M. W. Lingen
Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid
Blood,
June 15, 2001;
97(12):
3919 - 3924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Oitzinger, R. Hofer-Warbinek, J. A. Schmid, Y. Koshelnick, B. R. Binder, and R. de Martin
Adenovirus-mediated expression of a mutant I{kappa}B kinase 2 inhibits the response of endothelial cells to inflammatory stimuli
Blood,
March 15, 2001;
97(6):
1611 - 1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Zachary and G. Gliki
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
Cardiovasc Res,
February 16, 2001;
49(3):
568 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. MECHTCHERIAKOVA, G. SCHABBAUER, M. LUCERNA, M. CLAUSS, R. DE MARTIN, B. R. BINDER, and E. HOFER
Specificity, diversity, and convergence in VEGF and TNF-{alpha} signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells
FASEB J,
January 1, 2001;
15(1):
230 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sahni and C. W. Francis
Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation
Blood,
December 1, 2000;
96(12):
3772 - 3778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tapper and H. Herwald
Modulation of hemostatic mechanisms in bacterial infectious diseases
Blood,
October 1, 2000;
96(7):
2329 - 2337.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liu, J. C. Tsai, and W. C. Aird
Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor
Blood,
September 1, 2000;
96(5):
1772 - 1781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. GÖRLACH, R. P. BRANDES, S. BASSUS, N. KRONEMANN, C. M. KIRCHMAIER, R. BUSSE, and V. B. SCHINI-KERTH
Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets
FASEB J,
August 1, 2000;
14(11):
1518 - 1528.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Miraliakbari, N. A. Francalancia, R. M. Lust, J. A. Gerardo, P. C. Ng, Y. S. Sun, and W. R. Chitwood Jr
Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia
Ann. Thorac. Surg.,
June 1, 2000;
69(6):
1750 - 1754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Vidal, J. Aragones, A. Alfranca, and M. O. de Landazuri
Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1
Blood,
June 1, 2000;
95(11):
3387 - 3395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Chapman and N. D. Perkins
Inhibition of the RelA(p65) NF-kappa B Subunit by Egr-1
J. Biol. Chem.,
February 18, 2000;
275(7):
4719 - 4725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Blum, K. Issbruker, A. Willuweit, S. Hehlgans, M. Lucerna, D. Mechtcheriakova, K. Walsh, D. von der Ahe, E. Hofer, and M. Clauss
An Inhibitory Role of the Phosphatidylinositol 3-Kinase-signaling Pathway in Vascular Endothelial Growth Factor-induced Tissue Factor Expression
J. Biol. Chem.,
August 31, 2001;
276(36):
33428 - 33434.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |